Financial Ratios Ziyuanyuan Holdings Group Limited
Equities
8223
KYG9898B1041
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.190 HKD | +1.71% |
|
-8.46% | -25.16% |
04-02 | Ziyuanyuan To Issue Convertible Bonds In Aggregate Principal Amount Of HK$10 Million | RE |
03-31 | Ziyuanyuan Holdings Group Limited announced that it expects to receive HKD 10 million in funding | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.98 | 1.33 | 2.72 | 2.28 | -8.56 | |||||
Return On Equity % | 4.27 | 2.12 | 5.02 | 4.43 | -16.9 | |||||
Return on Common Equity | 4.31 | 1.82 | 5.22 | 4.7 | -17.31 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 100 | 85.04 | 39.23 | 21.63 | 6.61 | |||||
SG&A Margin | 30 | 35.85 | 15.55 | 8.31 | 5.13 | |||||
Income From Continuing Operations Margin % | 26.41 | 5.9 | 5.05 | 2.9 | -10.46 | |||||
Net Income Margin % | 26.61 | 5.02 | 5.18 | 3.04 | -10.62 | |||||
Net Avail. For Common Margin % | 26.61 | 5.02 | 5.18 | 3.04 | -10.62 | |||||
Normalized Net Income Margin | 18.12 | 2.65 | 4.95 | 2.68 | -3.43 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.11 | 0.22 | 0.54 | 0.79 | 0.82 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.09 | 3.22 | 2.42 | 1.92 | 2.5 | |||||
Quick Ratio | 3.07 | 2.37 | 1.67 | 1.6 | 1.98 | |||||
Operating Cash Flow to Current Liabilities | 0.46 | 0.21 | -0.22 | 0.67 | -0.9 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 36.58 | 67.15 | 79.23 | 45.56 | 69.67 | |||||
Total Debt / Total Capital | 26.78 | 40.17 | 44.21 | 31.3 | 41.06 | |||||
LT Debt/Equity | 2.55 | 26.5 | 29.49 | 11.57 | 31.93 | |||||
Long-Term Debt / Total Capital | 1.87 | 15.85 | 16.45 | 7.95 | 18.82 | |||||
Total Liabilities / Total Assets | 31 | 42.88 | 48.39 | 48.75 | 49.94 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -9.09 | 123.97 | 179.55 | 56.72 | 4.21 | |||||
Gross Profit, 1 Yr. Growth % | -9.09 | 90.46 | 28.96 | -13.55 | -68.15 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -23.64 | -50 | 139.42 | -10.13 | -476.34 | |||||
Net Income, 1 Yr. Growth % | -23.07 | -57.72 | 188.14 | -7.9 | -463.73 | |||||
Normalized Net Income, 1 Yr. Growth % | -46.54 | -67.21 | 421.41 | -15.2 | -233.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -23.07 | -57.72 | 188.13 | -7.9 | -439.07 | |||||
Common Equity, 1 Yr. Growth % | 0.7 | -0.94 | 2.45 | 1.82 | -4.15 | |||||
Total Assets, 1 Yr. Growth % | 3.06 | 21.19 | 13.05 | 2.14 | -1.89 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.38 | -8.1 | 1.05 | 2.25 | 3.74 | |||||
Cash From Operations, 1 Yr. Growth % | -507.39 | -48.67 | -241.34 | -502.94 | -205.88 | |||||
Capital Expenditures, 1 Yr. Growth % | 19.99 | -82.25 | 5.4 | -5.55 | -71.26 | |||||
Dividend Per Share, 1 Yr. Growth % | -21.5 | -3.25 | 8.58 | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.01 | 42.69 | 150.22 | 109.29 | 27.79 | |||||
Gross Profit, 2 Yr. CAGR % | 3.01 | 31.58 | 56.72 | 5.56 | -47.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -12.8 | -38.21 | 9.42 | 46.69 | 83.91 | |||||
Net Income, 2 Yr. CAGR % | -12.47 | -42.97 | 10.37 | 62.9 | 83.02 | |||||
Normalized Net Income, 2 Yr. CAGR % | -21.51 | -58.13 | 30.77 | 110.28 | 6.39 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -18.34 | -42.97 | 10.37 | 62.9 | 76.71 | |||||
Common Equity, 2 Yr. CAGR % | 3.29 | -0.12 | 0.74 | 2.13 | -1.21 | |||||
Total Assets, 2 Yr. CAGR % | 4.39 | 11.75 | 17.05 | 7.46 | 0.1 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.7 | -5.28 | -3.64 | 1.65 | 2.99 | |||||
Cash From Operations, 2 Yr. CAGR % | 40.88 | 44.61 | -14.82 | 139.63 | 106.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.17K | -53.86 | -56.75 | -0.23 | -47.9 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | -12.85 | 2.49 | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.97 | 33.44 | 78.54 | 114.07 | 65.88 | |||||
Gross Profit, 3 Yr. CAGR % | 8.97 | 26.43 | 30.7 | 28.51 | -29.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.44 | -27.55 | -2.94 | 2.47 | 100.81 | |||||
Net Income, 3 Yr. CAGR % | 10.72 | -31.33 | -2.14 | 3.91 | 112.91 | |||||
Normalized Net Income, 3 Yr. CAGR % | -3.91 | -41.32 | -2.95 | 13.19 | 80.72 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 0.46 | -34.43 | -2.14 | 3.91 | 107.99 | |||||
Common Equity, 3 Yr. CAGR % | 12.86 | 1.86 | 0.73 | 1.1 | -0.01 | |||||
Total Assets, 3 Yr. CAGR % | 7.7 | 9.72 | 12.18 | 11.85 | 4.24 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.7 | -1.68 | -3.22 | -1.71 | 2.34 | |||||
Cash From Operations, 3 Yr. CAGR % | 52.39 | 0.62 | 43.51 | 43.38 | 82.52 | |||||
Capital Expenditures, 3 Yr. CAGR % | 269.36 | 205.39 | -39.23 | -43.89 | -34.11 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | -6.23 | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 49.29 | 40.71 | 51.95 | 59.76 | 56.18 | |||||
Gross Profit, 5 Yr. CAGR % | 49.29 | 36.23 | 26.02 | 17.63 | -9.28 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 80.1 | 4.31 | 10.03 | -3.93 | 25.33 | |||||
Net Income, 5 Yr. CAGR % | 92.74 | 1.02 | 10.58 | -2.98 | 25.71 | |||||
Normalized Net Income, 5 Yr. CAGR % | 85.1 | -9.25 | 8.69 | -2.23 | 0.69 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 35.61 | -5.42 | 4.31 | -5.64 | 23.96 | |||||
Common Equity, 5 Yr. CAGR % | 20.69 | 22.8 | 7.84 | 1.97 | -0.05 | |||||
Total Assets, 5 Yr. CAGR % | 16.25 | 13.31 | 11.35 | 8.81 | 7.19 | |||||
Tangible Book Value, 5 Yr. CAGR % | 19.95 | 20.22 | 5.29 | -0.36 | -0.78 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.72 | -23.9 | 20.76 | 42.38 | 66.29 | |||||
Capital Expenditures, 5 Yr. CAGR % | 201.13 | 13.43 | 56.62 | 95.22 | -42.86 |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition